Free Trial
→ Could this be the start of AI’s Second Wind? (From Weiss Ratings) (Ad) Buy ACLX Stock  Free ACLX Stock Alerts

Arcellx (ACLX) Financials

Arcellx logo
$61.43 +1.13 (+1.87%)
Closing price 04/15/2025 04:00 PM Eastern
Extended Trading
$61.46 +0.04 (+0.06%)
As of 04/15/2025 05:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Arcellx

Annual Income Statements for Arcellx

This table shows Arcellx's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders		 -65 -189 -71 -107
Consolidated Net Income / (Loss)		 -65 -189 -71 -107
Net Income / (Loss) Continuing Operations		 -65 -189 -71 -107
Total Pre-Tax Income 		-65 -189 -70 -105
Total Operating Income		 -65 -191 -90 -138
Total Gross Profit		 0.00 0.00 110 108
Total Revenue		 0.00 0.00 110 108
Operating Revenue		 - 0.00 110 108
Total Cost of Revenue		 0.00 0.00 0.00 0.00
Total Operating Expenses		 65 191 200 246
Selling, General & Admin Expense		 18 42 66 88
Research & Development Expense		 47 150 134 157
Total Other Income / (Expense), net		 0.05 2.58 20 32
Interest & Investment Income		 - 4.30 24 33
Other Income / (Expense), net		 0.05 -1.72 -3.84 -1.03
Income Tax Expense		 - 0.00 0.66 2.07
Basic Earnings per Share		 ($145.55) ($5.19) ($1.47) ($2.00)
Weighted Average Basic Shares Outstanding		 446.38K 36.36M 48.06M 53.57M
Diluted Earnings per Share		 ($145.55) ($5.19) ($1.47) ($2.00)
Weighted Average Diluted Shares Outstanding		 446.38K 36.36M 48.06M 53.57M
Weighted Average Basic & Diluted Shares Outstanding		 - 47.84M 52.80M 54.94M

Quarterly Income Statements for Arcellx

This table shows Arcellx's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders		 -93 -39 -27 -24 -39 20 -7.20 -27 -26 -47
Consolidated Net Income / (Loss)		 -93 -39 -27 -24 -39 20 -7.20 -27 -26 -47
Net Income / (Loss) Continuing Operations		 -93 -39 -27 -24 -39 20 -7.20 -27 -26 -47
Total Pre-Tax Income 		-93 -39 -27 -24 -39 20 -7.20 -27 -26 -46
Total Operating Income		 -94 -40 -30 -30 -45 15 -16 -35 -34 -53
Total Gross Profit		 0.00 - 18 14 15 63 39 27 26 15
Total Revenue		 0.00 - 18 14 15 63 39 27 26 15
Operating Revenue		 0.00 - 18 14 15 63 39 27 26 15
Total Operating Expenses		 94 40 48 44 60 48 55 62 60 68
Selling, General & Admin Expense		 10 14 15 16 16 19 23 21 20 24
Research & Development Expense		 83 26 33 28 44 29 32 41 39 45
Total Other Income / (Expense), net		 1.00 1.01 3.44 5.42 5.52 5.47 8.61 8.13 7.97 7.58
Other Income / (Expense), net		 1.00 -3.29 3.44 5.42 5.52 -18 8.61 8.13 7.97 -26
Income Tax Expense		 0.00 - 0.33 -0.28 -0.01 0.62 0.00 0.34 0.22 1.51
Basic Earnings per Share		 ($2.12) ($0.98) ($0.58) ($0.50) ($0.81) $0.42 ($0.14) ($0.51) ($0.48) ($0.87)
Weighted Average Basic Shares Outstanding		 43.82M 36.36M 46.77M 48.11M 48.35M 48.06M 52.76M 53.52M 53.82M 53.57M
Diluted Earnings per Share		 ($2.12) ($0.98) ($0.58) ($0.50) ($0.81) $0.42 ($0.14) ($0.51) ($0.48) ($0.87)
Weighted Average Diluted Shares Outstanding		 43.82M 36.36M 46.77M 48.11M 48.35M 48.06M 52.76M 53.52M 53.82M 53.57M
Weighted Average Basic & Diluted Shares Outstanding		 43.85M 47.84M 47.99M 48.36M 48.69M 52.80M 53.50M 53.76M 54.07M 54.94M

Annual Cash Flow Statements for Arcellx

This table details how cash moves in and out of Arcellx's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Net Change in Cash & Equivalents		 -16 36 332 -291
Net Cash From Operating Activities		 -54 -99 208 -83
Net Cash From Continuing Operating Activities		 -54 -99 208 -83
Net Income / (Loss) Continuing Operations		 -65 -189 -71 -107
Consolidated Net Income / (Loss)		 -65 -189 -71 -107
Depreciation Expense		 1.04 1.32 2.04 5.19
Amortization Expense		 0.21 -2.13 -11 -15
Non-Cash Adjustments To Reconcile Net Income		 6.76 89 75 61
Changes in Operating Assets and Liabilities, net		 2.72 1.33 212 -27
Net Cash From Investing Activities		 -80 -118 -155 -183
Net Cash From Continuing Investing Activities		 -80 -118 -155 -183
Purchase of Property, Plant & Equipment		 -5.78 -2.28 -21 -13
Purchase of Investments		 -74 -274 -442 -597
Sale and/or Maturity of Investments		 0.00 158 309 428
Net Cash From Financing Activities		 118 253 279 -24
Net Cash From Continuing Financing Activities		 118 253 279 -24
Issuance of Common Equity		 0.00 260 301 1.16
Other Financing Activities, net		 0.05 -7.21 -22 -25
Cash Income Taxes Paid		 - 0.00 0.21 1.64

Quarterly Cash Flow Statements for Arcellx

This table details how cash moves in and out of Arcellx's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents		 -108 7.42 211 29 -175 268 -242 -55 62 -56
Net Cash From Operating Activities		 -17 -28 182 -23 -10 58 -32 -36 31 -46
Net Cash From Continuing Operating Activities		 -17 -28 182 -23 -10 58 -32 -36 31 -46
Net Income / (Loss) Continuing Operations		 -93 -39 -27 -24 -39 20 -7.20 -27 -26 -47
Consolidated Net Income / (Loss)		 -93 -39 -27 -24 -39 20 -7.20 -27 -26 -47
Depreciation Expense		 0.34 0.42 0.43 0.44 0.45 0.72 0.83 1.24 1.33 1.79
Amortization Expense		 -0.81 -1.36 -1.98 -2.71 -2.42 -3.94 -4.36 -4.13 -3.40 -3.57
Non-Cash Adjustments To Reconcile Net Income		 70 7.75 -8.05 11 29 43 17 15 15 15
Changes in Operating Assets and Liabilities, net		 6.43 4.66 219 -7.78 1.81 -1.04 -38 -21 44 -12
Net Cash From Investing Activities		 -81 34 -67 51 -160 21 -207 -7.87 36 -4.12
Net Cash From Continuing Investing Activities		 -81 34 -67 51 -160 21 -207 -7.87 36 -4.12
Purchase of Property, Plant & Equipment		 -0.39 -1.28 -0.98 -7.23 -7.93 -5.29 -6.43 -3.21 -2.29 -1.50
Purchase of Investments		 -129 -26 -162 - -238 -42 -318 -83 -60 -136
Sale and/or Maturity of Investments		 48 61 96 59 86 69 118 78 98 134
Net Cash From Financing Activities		 -9.71 1.31 95 0.12 -4.99 189 -2.99 -10 -4.66 -6.02
Net Cash From Continuing Financing Activities		 -9.71 1.31 95 0.12 -4.99 189 -2.99 -10 -4.66 -6.02
Issuance of Common Equity		 -0.82 - 100 0.53 -0.53 201 0.00 0.65 - 0.52
Other Financing Activities, net		 -8.89 1.31 -4.56 -0.41 -4.46 -12 -2.99 -11 -4.66 -6.54
Cash Income Taxes Paid		 - - 0.00 0.21 - - 0.00 1.07 0.40 0.17

Annual Balance Sheets for Arcellx

This table presents Arcellx's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Total Assets		 129 314 825 711
Total Current Assets		 113 267 716 599
Cash & Equivalents		 31 64 395 106
Restricted Cash		 - 0.00 1.90 0.21
Short-Term Investments		 74 191 307 482
Prepaid Expenses		 8.19 12 12 12
Plant, Property, & Equipment, net		 10 11 43 46
Total Noncurrent Assets		 5.66 36 66 66
Long-Term Investments		 - 0.00 27 38
Other Noncurrent Operating Assets		 5.66 36 39 27
Total Liabilities & Shareholders' Equity		 129 314 825 711
Total Liabilities		 17 109 340 257
Total Current Liabilities		 15 57 118 125
Accounts Payable		 1.33 9.05 2.62 2.10
Accrued Expenses		 13 12 18 57
Current Deferred Revenue		 0.18 0.00 0.00 0.00
Other Current Liabilities		 0.15 36 97 67
Total Noncurrent Liabilities		 2.07 52 222 131
Noncurrent Deferred Revenue		 1.90 0.00 0.00 0.00
Other Noncurrent Operating Liabilities		 0.18 52 222 131
Commitments & Contingencies		 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 233 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -122 205 485 455
Total Preferred & Common Equity		 -122 205 485 455
Preferred Stock		 0.00 0.00 0.00 0.00
Total Common Equity		 -122 205 485 455
Common Stock		 8.62 524 874 951
Retained Earnings		 -130 -319 -389 -497
Accumulated Other Comprehensive Income / (Loss)		 -0.02 -0.22 0.55 0.85

Quarterly Balance Sheets for Arcellx

This table presents Arcellx's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets		 337 623 624 614 780 734 765
Total Current Assets		 290 571 558 491 589 530 587
Cash & Equivalents		 57 275 304 126 155 100 162
Restricted Cash		 - - - - 0.21 0.21 0.21
Short-Term Investments		 224 259 203 314 419 417 412
Accounts Receivable		 - 21 29 31 0.00 0.00 0.00
Prepaid Expenses		 9.52 17 22 20 15 13 13
Plant, Property, & Equipment, net		 10 14 22 38 45 46 47
Total Noncurrent Assets		 37 37 43 85 146 158 129
Long-Term Investments		 - - - 43 117 130 102
Other Noncurrent Operating Assets		 37 37 43 42 29 28 26
Total Liabilities & Shareholders' Equity		 337 623 624 614 780 734 765
Total Liabilities		 101 319 330 348 283 247 282
Total Current Liabilities		 45 166 156 173 108 88 137
Accounts Payable		 2.96 4.53 5.69 7.19 3.10 4.87 5.99
Accrued Expenses		 11 14 12 17 34 42 43
Current Deferred Revenue		 0.00 107 94 94 31 15 70
Other Current Liabilities		 31 40 44 55 40 26 18
Total Noncurrent Liabilities		 56 153 174 175 175 159 145
Noncurrent Deferred Revenue		 0.00 106 124 121 112 96 83
Other Noncurrent Operating Liabilities		 29 47 49 54 63 63 62
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 236 304 294 266 497 487 483
Total Preferred & Common Equity		 236 304 294 266 497 487 483
Total Common Equity		 236 304 294 266 497 487 483
Common Stock		 516 650 664 676 894 912 931
Retained Earnings		 -280 -346 -370 -409 -397 -424 -450
Accumulated Other Comprehensive Income / (Loss)		 -0.40 0.09 -0.01 -0.07 -0.51 -0.79 1.90

Annual Metrics and Ratios for Arcellx

This table displays calculated financial ratios and metrics derived from Arcellx's official financial filings.

Metric 2021 2022 2023 2024
Growth Metrics		 - - - -
Revenue Growth		 0.00% 0.00% 0.00% -2.16%
EBITDA Growth		 0.00% -204.13% 46.99% -44.92%
EBIT Growth		 0.00% -197.03% 51.43% -47.89%
NOPAT Growth		 0.00% -194.16% 53.01% -53.06%
Net Income Growth		 0.00% -190.41% 62.53% -51.86%
EPS Growth		 0.00% 96.43% 71.68% -36.05%
Operating Cash Flow Growth		 0.00% -83.09% 309.03% -140.21%
Free Cash Flow Firm Growth		 0.00% 0.00% 273.17% -228.61%
Invested Capital Growth		 0.00% -788.30% -392.59% 30.38%
Revenue Q/Q Growth		 0.00% 0.00% 133.87% -30.73%
EBITDA Q/Q Growth		 0.00% -14.17% 25.52% -99.44%
EBIT Q/Q Growth		 0.00% -13.28% 28.57% -120.24%
NOPAT Q/Q Growth		 0.00% -11.23% 37.96% -98.17%
Net Income Q/Q Growth		 0.00% -10.76% 45.42% -165.56%
EPS Q/Q Growth		 0.00% 88.51% 48.78% -181.69%
Operating Cash Flow Q/Q Growth		 0.00% -6.40% 70.41% -501.07%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 36.06% -144.41%
Invested Capital Q/Q Growth		 0.00% -185.97% -13.47% 12.36%
Profitability Metrics		 - - - -
Gross Margin		 0.00% 0.00% 100.00% 100.00%
EBITDA Margin		 0.00% 0.00% -93.12% -137.93%
Operating Margin		 0.00% 0.00% -81.47% -127.46%
EBIT Margin		 0.00% 0.00% -84.96% -128.41%
Profit (Net Income) Margin		 0.00% 0.00% -64.08% -99.46%
Tax Burden Percent		 100.00% 100.00% 100.95% 101.97%
Interest Burden Percent		 100.00% 97.77% 74.72% 75.96%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -58.08% -119.11% -20.48% -22.84%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% -16.46% -18.04%
Return on Assets (ROA)		 0.00% 0.00% -12.41% -13.97%
Return on Common Equity (ROCE)		 63.09% -31.37% -20.48% -22.84%
Return on Equity Simple (ROE_SIMPLE)		 53.47% -92.06% -14.56% -23.60%
Net Operating Profit after Tax (NOPAT)		 -46 -134 -63 -96
NOPAT Margin		 0.00% 0.00% -57.03% -89.22%
Net Nonoperating Expense Percent (NNEP)		 -18.60% -30.49% -1.58% -1.63%
Return On Investment Capital (ROIC_SIMPLE)		 - -65.32% -12.96% -21.17%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 60.14% 81.91%
R&D to Revenue		 0.00% 0.00% 121.33% 145.54%
Operating Expenses to Revenue		 0.00% 0.00% 181.47% 227.46%
Earnings before Interest and Taxes (EBIT)		 -65 -193 -94 -139
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -64 -194 -103 -149
Valuation Ratios		 - - - -
Price to Book Value (P/BV)		 0.00 6.63 5.57 9.12
Price to Tangible Book Value (P/TBV)		 0.00 6.63 5.57 9.12
Price to Revenue (P/Rev)		 0.00 0.00 24.49 38.42
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 34.84 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 17.87 32.62
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 9.50 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 14.83 0.00
Leverage & Solvency		 - - - -
Debt to Equity		 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00
Financial Leverage		 -0.94 -1.13 -1.43 -1.44
Leverage Ratio		 1.15 1.40 1.65 1.63
Compound Leverage Factor		 1.15 1.37 1.23 1.24
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 208.63% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 -108.63% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00
Altman Z-Score		 2.22 4.84 4.74 9.03
Noncontrolling Interest Sharing Ratio		 208.63% 73.66% 0.00% 0.00%
Liquidity Ratios		 - - - -
Current Ratio		 7.60 4.71 6.06 4.78
Quick Ratio		 7.05 4.50 5.94 4.68
Cash Flow Metrics		 - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -77 133 -171
Operating Cash Flow to CapEx		 -937.89% -4,361.13% 968.70% -621.31%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - -
Asset Turnover		 0.00 0.00 0.19 0.14
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 4.09 2.42
Accounts Payable Turnover		 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - -
Invested Capital		 7.25 -50 -246 -171
Invested Capital Turnover		 0.00 0.00 -0.75 -0.52
Increase / (Decrease) in Invested Capital		 0.00 -57 -196 75
Enterprise Value (EV)		 253 1,104 1,971 3,521
Market Capitalization		 124 1,359 2,702 4,147
Book Value per Share		 ($272.22) $4.67 $9.97 $8.41
Tangible Book Value per Share		 ($272.22) $4.67 $9.97 $8.41
Total Capital		 112 205 485 455
Total Debt		 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00
Net Debt		 -105 -255 -731 -626
Capital Expenditures (CapEx)		 5.78 2.28 21 13
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -6.65 -45 -106 -114
Debt-free Net Working Capital (DFNWC)		 98 210 598 474
Net Working Capital (NWC)		 98 210 598 474
Net Nonoperating Expense (NNE)		 19 55 7.77 11
Net Nonoperating Obligations (NNO)		 -105 -255 -731 -626
Total Depreciation and Amortization (D&A)		 1.25 -0.80 -9.01 -10
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% -95.90% -105.32%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 542.18% 439.06%
Net Working Capital to Revenue		 0.00% 0.00% 542.18% 439.06%
Earnings Adjustments		 - - - -
Adjusted Basic Earnings per Share		 $0.00 ($5.19) ($1.47) ($2.00)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 36.36M 48.06M 53.57M
Adjusted Diluted Earnings per Share		 $0.00 ($5.19) ($1.47) ($2.00)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 36.36M 48.06M 53.57M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 47.84M 52.80M 54.94M
Normalized Net Operating Profit after Tax (NOPAT)		 -46 -134 -63 -96
Normalized NOPAT Margin		 0.00% 0.00% -57.03% -89.22%
Pre Tax Income Margin		 0.00% 0.00% -63.48% -97.54%
Debt Service Ratios		 - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Payout Ratios		 - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -1.06% 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for Arcellx

This table displays calculated financial ratios and metrics derived from Arcellx's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 119.16% 91.47% 74.03% -75.83%
EBITDA Growth		 -456.32% -119.09% -11.27% 13.54% 55.74% 85.42% 62.42% -12.65% 32.91% -1,150.61%
EBIT Growth		 -443.41% -109.44% -3.74% 21.57% 57.64% 92.54% 73.36% -11.29% 34.82% -2,343.42%
NOPAT Growth		 -448.66% -93.27% -16.73% 5.53% 52.21% 151.94% 48.09% -18.38% 25.07% -355.83%
Net Income Growth		 -443.41% -88.64% -5.00% 22.48% 57.65% 150.89% 73.68% -14.04% 34.24% -337.26%
EPS Growth		 93.89% 97.61% 53.60% 40.48% 61.79% 142.86% 75.86% -2.00% 40.74% -307.14%
Operating Cash Flow Growth		 -36.20% -27.73% 658.65% -0.30% 39.32% 311.66% -117.53% -60.29% 404.09% -179.02%
Free Cash Flow Firm Growth		 0.00% 0.00% 739.54% 641.72% 447.43% 622.28% -120.52% -137.10% -126.76% -153.17%
Invested Capital Growth		 0.00% -788.30% -1,451.73% -1,379.49% -1,141.46% -392.59% 15.32% 24.88% 9.86% 30.38%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% -20.15% 4.58% 322.20% -37.83% -30.24% -4.94% -41.35%
EBITDA Q/Q Growth		 -205.61% 52.61% 31.43% 7.54% -56.43% 84.38% -66.36% -177.20% 6.84% -191.11%
EBIT Q/Q Growth		 -201.81% 53.39% 33.64% 10.66% -63.00% 91.79% -122.92% -273.17% 4.53% -207.67%
NOPAT Q/Q Growth		 -200.02% 57.39% 23.86% 2.95% -51.77% 146.31% -176.07% -121.33% 3.94% -58.12%
Net Income Q/Q Growth		 -201.81% 58.02% 29.87% 12.76% -64.90% 150.45% -136.27% -277.91% 4.91% -82.01%
EPS Q/Q Growth		 -152.38% 53.77% 40.82% 13.79% -62.00% 151.85% -133.33% -264.29% 5.88% -81.25%
Operating Cash Flow Q/Q Growth		 26.16% -65.30% 761.49% -112.42% 55.33% 676.60% -154.78% -13.61% 184.74% -249.84%
Free Cash Flow Firm Q/Q Growth		 -25.26% 160.34% 674.44% -7.45% -19.67% 25.44% -122.00% -67.33% 42.06% -149.23%
Invested Capital Q/Q Growth		 -204.87% -185.97% -360.85% 7.42% -1.75% -13.47% 20.78% 17.88% -22.11% 12.36%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 0.00% 0.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin		 0.00% 0.00% -159.45% -184.65% -276.19% -10.22% -27.34% -108.64% -106.47% -528.48%
Operating Margin		 0.00% 0.00% -170.04% -206.68% -299.94% 23.75% -40.27% -127.79% -129.14% -348.17%
EBIT Margin		 0.00% 0.00% -150.82% -168.76% -263.03% -5.11% -18.34% -98.09% -98.52% -516.82%
Profit (Net Income) Margin		 0.00% 0.00% -152.66% -166.79% -262.99% 31.42% -18.34% -99.34% -99.37% -308.40%
Tax Burden Percent		 100.00% 100.00% 101.22% 98.83% 99.98% 96.96% 100.00% 101.27% 100.87% 103.30%
Interest Burden Percent		 100.00% 90.07% 100.00% 100.00% 100.00% -633.82% 100.00% 100.00% 100.00% 57.77%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 3.04% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -72.10% -119.11% -71.47% -59.31% -51.56% -20.48% -12.63% -13.80% -10.79% -22.84%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% -6.21% -10.89% -26.08% -0.99% -3.44% -20.91% -22.26% -72.61%
Return on Assets (ROA)		 0.00% 0.00% -6.29% -10.77% -26.07% 6.09% -3.44% -21.18% -22.46% -43.33%
Return on Common Equity (ROCE)		 -72.10% -31.37% -71.47% -59.31% -51.56% -20.48% -12.63% -13.80% -10.79% -22.84%
Return on Equity Simple (ROE_SIMPLE)		 -72.10% 0.00% -62.55% -62.34% -48.67% 0.00% -10.18% -11.06% -8.37% 0.00%
Net Operating Profit after Tax (NOPAT)		 -66 -28 -21 -21 -31 15 -11 -24 -24 -37
NOPAT Margin		 0.00% 0.00% -119.03% -144.68% -209.96% 23.03% -28.19% -89.45% -90.40% -243.72%
Net Nonoperating Expense Percent (NNEP)		 -21.41% -6.11% -1.62% -0.78% -2.15% 1.08% 0.63% -0.47% -0.40% -1.46%
Return On Investment Capital (ROIC_SIMPLE)		 - -13.66% - - - 3.00% - - - -8.18%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 86.18% 108.62% 107.05% 30.67% 57.95% 78.24% 78.65% 155.70%
R&D to Revenue		 0.00% 0.00% 183.85% 198.06% 292.89% 45.58% 82.33% 149.55% 150.49% 292.47%
Operating Expenses to Revenue		 0.00% 0.00% 270.04% 306.68% 399.94% 76.25% 140.27% 227.79% 229.14% 448.17%
Earnings before Interest and Taxes (EBIT)		 -93 -43 -27 -24 -39 -3.23 -7.20 -27 -26 -79
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -93 -44 -29 -26 -41 -6.45 -11 -30 -28 -81
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 3.48 6.63 4.85 5.17 6.52 5.57 6.82 6.06 9.29 9.12
Price to Tangible Book Value (P/TBV)		 3.48 6.63 4.85 5.17 6.52 5.57 6.82 6.06 9.29 9.12
Price to Revenue (P/Rev)		 0.00 0.00 82.29 47.11 36.78 24.49 25.72 20.40 28.81 38.42
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 52.50 31.39 26.55 17.87 20.47 15.93 24.47 32.62
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 8.15 8.77 10.28 9.50 0.00 0.00 183.18 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 8.55 10.79 12.82 14.83 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.07 -1.13 -1.40 -1.32 -1.47 -1.43 -1.53 -1.48 -1.55 -1.44
Leverage Ratio		 1.43 1.40 1.64 1.62 1.89 1.65 1.75 1.74 1.84 1.63
Compound Leverage Factor		 1.43 1.26 1.64 1.62 1.89 -10.46 1.75 1.74 1.84 0.94
Debt to Total Capital		 10.27% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 10.27% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 89.73% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 -0.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 1.49 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 -0.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 -0.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 2.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 -0.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 3.69 6.41 2.66 2.63 2.55 5.10 7.34 7.16 9.53 9.31
Noncontrolling Interest Sharing Ratio		 0.00% 73.66% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 6.48 4.71 3.44 3.57 2.84 6.06 5.46 6.01 4.29 4.78
Quick Ratio		 6.27 4.50 3.34 3.43 2.72 5.94 5.32 5.85 4.19 4.68
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -48 29 226 209 168 210 -46 -77 -45 -112
Operating Cash Flow to CapEx		 -4,324.42% -2,156.74% 18,575.71% -312.88% -127.44% 1,100.47% -496.07% -1,128.20% 1,341.44% -3,070.71%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.04 0.06 0.10 0.19 0.19 0.21 0.23 0.14
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 1.48 2.02 1.97 4.09 4.44 4.22 3.65 2.42
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 -17 -50 -230 -213 -217 -246 -195 -160 -195 -171
Invested Capital Turnover		 0.00 0.00 -0.17 -0.33 -0.40 -0.75 -0.62 -0.78 -0.76 -0.52
Increase / (Decrease) in Invested Capital		 -17 -57 -247 -229 -199 -196 35 53 21 75
Enterprise Value (EV)		 569 1,104 940 1,011 1,252 1,971 2,695 2,306 3,812 3,521
Market Capitalization		 822 1,359 1,474 1,518 1,735 2,702 3,386 2,953 4,489 4,147
Book Value per Share		 $5.39 $4.67 $6.35 $6.12 $5.50 $9.97 $9.41 $9.11 $8.99 $8.41
Tangible Book Value per Share		 $5.39 $4.67 $6.35 $6.12 $5.50 $9.97 $9.41 $9.11 $8.99 $8.41
Total Capital		 263 205 304 294 266 485 497 487 483 455
Total Debt		 27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -254 -255 -534 -506 -483 -731 -691 -647 -677 -626
Capital Expenditures (CapEx)		 0.39 1.28 0.98 7.23 7.93 5.29 6.43 3.21 2.29 1.50
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -35 -45 -128 -105 -121 -106 -93 -75 -124 -114
Debt-free Net Working Capital (DFNWC)		 246 210 405 402 318 598 481 442 450 474
Net Working Capital (NWC)		 246 210 405 402 318 598 481 442 450 474
Net Nonoperating Expense (NNE)		 27 11 6.02 3.16 7.93 -5.30 -3.87 2.71 2.34 9.87
Net Nonoperating Obligations (NNO)		 -254 -255 -534 -506 -483 -731 -691 -647 -678 -626
Total Depreciation and Amortization (D&A)		 -0.47 -0.94 -1.55 -2.27 -1.97 -3.22 -3.53 -2.89 -2.07 -1.78
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% -716.18% -324.48% -257.38% -95.90% -70.86% -51.80% -79.69% -105.32%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 2,262.78% 1,247.77% 674.79% 542.18% 365.20% 305.30% 288.98% 439.06%
Net Working Capital to Revenue		 0.00% 0.00% 2,262.78% 1,247.77% 674.79% 542.18% 365.20% 305.30% 288.98% 439.06%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($2.12) ($0.98) $0.00 ($0.50) ($0.81) $0.42 ($0.14) ($0.51) ($0.48) ($0.87)
Adjusted Weighted Average Basic Shares Outstanding		 43.82M 36.36M 0.00 48.11M 48.44M 48.06M 52.76M 53.52M 53.82M 53.57M
Adjusted Diluted Earnings per Share		 ($2.12) ($0.98) $0.00 ($0.50) ($0.81) $0.42 ($0.14) ($0.51) ($0.48) ($0.87)
Adjusted Weighted Average Diluted Shares Outstanding		 43.82M 36.36M 0.00 48.11M 48.44M 48.06M 52.76M 53.52M 53.82M 53.57M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 43.85M 47.84M 0.00 48.36M 48.69M 52.80M 53.50M 53.76M 54.07M 54.94M
Normalized Net Operating Profit after Tax (NOPAT)		 -66 -28 -21 -21 -31 15 -11 -24 -24 -37
Normalized NOPAT Margin		 0.00% 0.00% -119.03% -144.68% -209.96% 23.03% -28.19% -89.45% -90.40% -243.72%
Pre Tax Income Margin		 0.00% 0.00% -150.82% -168.76% -263.03% 32.41% -18.34% -98.09% -98.52% -298.55%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Arcellx's Financials

When does Arcellx's financial year end?

According to the most recent income statement we have on file, Arcellx's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Arcellx's net income changed over the last 3 years?

In the past 3 years, Arcellx's net income has ranged from -$188.68 million in 2022 to -$64.97 million in 2021, and is currently -$107.35 million as of their latest financial filing in 2024.

What is Arcellx's operating income?
Arcellx's total operating income in 2024 was -$137.57 million, based on the following breakdown:
  • Total Gross Profit: $107.94 million
  • Total Operating Expenses: $245.51 million
How has Arcellx revenue changed over the last 3 years?

Over the last 3 years, Arcellx's total revenue changed from $0.00 in 2021 to $107.94 million in 2024, a change of 10,793,600,000.0%.

How much debt does Arcellx have?

Arcellx's total liabilities were at $256.54 million at the end of 2024, a 24.5% decrease from 2023, and a 1,416.3% increase since 2021.

How much cash does Arcellx have?

In the past 3 years, Arcellx's cash and equivalents has ranged from $30.83 million in 2021 to $394.58 million in 2023, and is currently $105.68 million as of their latest financial filing in 2024.

How has Arcellx's book value per share changed over the last 3 years?

Over the last 3 years, Arcellx's book value per share changed from -272.22 in 2021 to 8.41 in 2024, a change of -103.1%.

Remove Ads

Related Companies

This page (NASDAQ:ACLX) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners
Two Unmistakable Patterns Return…
The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...
Golden Portfolio | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
Crypto’s crashing…but we’re still profiting
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....
Crypto Swap Profits | Sponsored
Is it CRAZY to still want reliable profits, despite this market?
Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...
Brownstone Research | Sponsored
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...
Weiss Ratings | Sponsored
Tariffs. Volatility. Fear. Here’s the Plan.
Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...
Investors Alley | Sponsored
This story is about to go viral
This Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...
Stansberry Research | Sponsored
How War with China Could Start in 128 Days
The clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...
Behind the Markets | Sponsored